These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 30559466)

  • 41. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
    Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
    Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications.
    Cobo-Calvo Á; Sepúlveda M; Bernard-Valnet R; Ruiz A; Brassat D; Martínez-Yélamos S; Saiz A; Marignier R
    Mult Scler; 2016 Mar; 22(3):312-9. PubMed ID: 26209592
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.
    de Seze J
    Curr Opin Neurol; 2019 Feb; 32(1):111-114. PubMed ID: 30562266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
    Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J
    J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
    Jarius S; Pellkofer H; Siebert N; Korporal-Kuhnke M; Hümmert MW; Ringelstein M; Rommer PS; Ayzenberg I; Ruprecht K; Klotz L; Asgari N; Zrzavy T; Höftberger R; Tobia R; Buttmann M; Fechner K; Schanda K; Weber M; Asseyer S; Haas J; Lechner C; Kleiter I; Aktas O; Trebst C; Rostasy K; Reindl M; Kümpfel T; Paul F; Wildemann B;
    J Neuroinflammation; 2020 Sep; 17(1):261. PubMed ID: 32883348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids.
    Matsumoto Y; Kaneko K; Takahashi T; Takai Y; Namatame C; Kuroda H; Misu T; Fujihara K; Aoki M
    Brain; 2023 Sep; 146(9):3938-3948. PubMed ID: 37061817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature.
    Ikeda A; Watanabe Y; Kaba H; Kaneko K; Takahashi T; Takeshita S
    Brain Dev; 2019 Apr; 41(4):367-372. PubMed ID: 30447856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
    Chen JJ; Bhatti MT
    Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes.
    Ferilli MAN; Valeriani M; Papi C; Papetti L; Ruscitto C; Figà Talamanca L; Ursitti F; Moavero R; Vigevano F; Iorio R
    Mult Scler Relat Disord; 2021 May; 50():102837. PubMed ID: 33636614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of myelin oligodendrocyte glycoprotein antibodies in pediatric onset multiple sclerosis.
    Solmaz I; Doran T; Yousefi M; Konuskan B; Oncel I; Vural A; Anlar B
    Mult Scler Relat Disord; 2022 Dec; 68():104097. PubMed ID: 35998500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The spectrum of MOG autoantibody-associated demyelinating diseases.
    Reindl M; Di Pauli F; Rostásy K; Berger T
    Nat Rev Neurol; 2013 Aug; 9(8):455-61. PubMed ID: 23797245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neuromyelitis optica spectrum disorders: A nationwide Portuguese clinical epidemiological study.
    Santos E; Rocha AL; Oliveira V; Ferro D; Samões R; Sousa AP; Figueiroa S; Mendonça T; Abreu P; Guimarães J; Sousa R; Melo C; Correia I; Durães J; Sousa L; Ferreira J; de Sá J; Sousa F; Sequeira M; Correia AS; André AL; Basílio C; Arenga M; Mendes I; Marques IB; Perdigão S; Felgueiras H; Alves I; Correia F; Barroso C; Morganho A; Carmona C; Palavra F; Santos M; Salgado V; Palos A; Nzwalo H; Timóteo A; Guerreiro R; Isidoro L; Boleixa D; Carneiro P; Neves E; Silva AM; Gonçalves G; Leite MI; Sá MJ
    Mult Scler Relat Disord; 2021 Nov; 56():103258. PubMed ID: 34583213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations.
    Juryńczyk M; Jacob A; Fujihara K; Palace J
    Pract Neurol; 2019 Jun; 19(3):187-195. PubMed ID: 30530724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-ADEM encephalitis in patients with myelin oligodendrocyte glycoprotein antibodies: a systematic review.
    Vega E; Arrambide G; Olivé G; Castillo M; Felipe-Rucián A; Tintoré M; Montalban X; Espejo C; Sepúlveda M; Armangué T; Cobo-Calvo A
    Eur J Neurol; 2023 May; 30(5):1515-1527. PubMed ID: 36704861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder.
    Ojha PT; Aglave VB; Soni G; Jagiasi KA; Singh RK; Singh RK; Nagendra S
    Neurol India; 2020; 68(5):1106-1114. PubMed ID: 33109860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: A case report.
    Uchigami H; Arai N; Sekiguchi M; Ogawa A; Yasuda T; Seto A; Takahashi T; Takeuchi S
    Mult Scler Relat Disord; 2020 Feb; 38():101500. PubMed ID: 31733424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.
    Dos Passos GR; Oliveira LM; da Costa BK; Apostolos-Pereira SL; Callegaro D; Fujihara K; Sato DK
    Front Neurol; 2018; 9():217. PubMed ID: 29670575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.